Resonant Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $262K | Sell |
|
|||||
|
2025
Q2 | $304K | Buy |
|
|||||
|
2025
Q1 | $243K | Sell |
|
|||||
|
2024
Q4 | $250K | Buy |
|
|||||
|
2024
Q3 | $207K | Buy |
|
|||||
|
2024
Q2 | $272K | Buy |
|
|||||
|
2024
Q1 | $263K | Buy |
|
|||||
|
2023
Q4 | $202K | Sell |
|
|||||
|
2023
Q3 | $252K | Buy |
|
|||||
|
2023
Q2 | $342K | Sell |
|
|||||
|
2023
Q1 | $380K | Sell |
|
|||||
|
2022
Q4 | $380K | Buy |
|
|||||
|
2022
Q3 | $421K | Sell |
|
|||||
|
2022
Q2 | $506K | Buy |
|
|||||
|
2022
Q1 | $652K | Sell |
|
|||||
|
2021
Q4 | $690K | Sell |
|
|||||
|
2021
Q3 | $699K | Hold |
|
|||||
|
2021
Q2 | $639K | Buy |
|
|||||
|
2021
Q1 | $516K | Hold |
|
|||||
|
2020
Q4 | $562K | Sell |
|
|||||
|
2020
Q3 | $516K | Hold |
|
|||||
|
2020
Q2 | $447K | Hold |
|
|||||
|
2020
Q1 | $406K | Sell |
|
|||||
|
2019
Q4 | $630K | Buy |
|